[FOR IMMEDIATE RELEASE]
/

Union Medical Healthcare Announces Sales Performance
during National Day Golden Week Holiday

(16 October 2017, Hong Kong) Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company"; together with its subsidiaries, the "Group", SEHK stock code: 2138), a leading aesthetic medical service provider in Hong Kong, announces today its sales performance during the National Day Golden Week Holiday from 1 to 10 October 2017 (the "Period").

During the Period, the Company's unaudited cash sales recorded an increase of approximately 25%, representing a significant increase of 78% compared with the 14% growth for the same period last year.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of Union Medical Healthcare said, "As the industry leader, Union Medical Healthcare has been dedicating in expanding our scope of services for diversity. The new business segment not only contributed to an increase in our contracted sales, it also created a lot of cross sale opportunities for our existing clients and new PRC clients. We will continue to look for partnership in hotel accommodations, travel agencies and airlines to expand our medical tourism business, which will serve as momentum for the Group's business going forward."

- End -

About Union Medical Healthcare Limited
Union Medical Healthcare is principally engaged in the provision of one-stop aesthetic medical, beauty and health management solutions with 46 clinics and servicing centres across Hong Kong, the PRC and Macao as at 30 September 2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened re:HEALTH, a one-stop health management centre, to provide a full range of services and products, including comprehensive health screening, health product and health management services. The Group is the largest aesthetic medical service provider in Hong Kong in terms of revenue. The Group ranked first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic injection procedures performed involving utilization of the top-six revenue-generating aesthetic medications in Hong Kong; and was the Black Diamond Provider of the transparent orthodontic device for teeth alignment, Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN, a well-recognized brand in Hong Kong, with the reputation of being a premier provider of aesthetic medical services in Hong Kong.

For further information, please contact:
iPR Ogilvy & Mather
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639
Fax: (852) 3170 6606
Email: umh@iprogilvy.com